Compugen Fourth Quarter 2011 Conference Call Scheduled for Tuesday, February 7, 2012 at 10:00 AM EST|Feb 05, 2012
Tel Aviv, Israel, January 31, 2012 --- Compugen Ltd. (NASDAQ: CGEN) today announced that the Company will host a conference call at 10:00 AM EST on Tuesday, February 7, 2012 to review fourth quarter 2011 results. The quarterly results will be released on the Company’s website (www.cgen.com), prior to the conference call.
Compugen Cancer Target Results Demonstrate Significant Potential for Cancer Immunotherapy |Feb 02, 2012
Expression levels of CGEN-15001T on various solid, hematological cancer cells and immune cells combined with its immunomodulatory activities support its potential use as a powerful drug target for cancer immunotherapy
Compugen Presents Three Product Candidates for Treatment of Autoimmune Diseases at the Immunotherapeutics & Immunomonitoring Conference|Jan 30, 2012
Presentation demonstrates the therapeutic effects of CGEN-15001, CGEN-15021 and CGEN-15091 in disease animal models of rheumatoid arthritis and multiple sclerosis